Latest filing published 08 Sept 2026 for Myriad Genetics INC, €12k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Jennifer Lynne Fox span 2 companies, the busiest being Emergent BioSolutions Inc. and Myriad Genetics Inc. We count 17 filings; the first trade dates from 1 March 2022 and the latest from 3 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 8 September 2026, reports a share grant of €12k in Myriad Genetics Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations